Efficacy of 1 versus 3 days of intravenous amikacin as a prophylaxis for patients undergoing transurethral resection of the prostate: A prospective randomized trial.


Journal

Indian journal of urology : IJU : journal of the Urological Society of India
ISSN: 0970-1591
Titre abrégé: Indian J Urol
Pays: India
ID NLM: 8510441

Informations de publication

Date de publication:
Historique:
received: 05 09 2020
revised: 03 11 2020
accepted: 13 02 2021
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 10 6 2021
Statut: ppublish

Résumé

There are no uniform guidelines on the duration of antibiotic prophylaxis for transurethral resection of the prostate (TURP). The objective of this study was to evaluate the efficacy of 1 day versus 3 days of intravenous amikacin as prophylaxis, before TURP. In this prospective randomized control trial, patients with sterile preoperative urine culture were randomized to receive either 1 day (Group A) or 3 days (Group B) of intravenous (IV) amikacin. All patients had their catheter removed on the 3 Of the 338 patients randomized, 314 patients were evaluable until day 7 and 307 until 1 month. Bacteriuria rate at day 4 (Group A: 8.8% [95% confidence interval (CI): 4.2-13.2]; Group B: 4.4% [95% CI: 1.2%-7.7%], One day is possibly noninferior to 3 days of IV amikacin as prophylaxis in patients undergoing TURP with respect to bacteriuria and symptomatic UTI, with an added advantage of lower antibiotic resistance.

Identifiants

pubmed: 34103795
doi: 10.4103/iju.IJU_494_20
pii: IJU-37-133
pmc: PMC8173930
doi:

Types de publication

Journal Article

Langues

eng

Pagination

133-139

Informations de copyright

Copyright: © 2021 Indian Journal of Urology.

Déclaration de conflit d'intérêts

Conflicts of interest: There are no conflicts of interest.

Références

Infection. 1994 Sep-Oct;22(5):347-9
pubmed: 7843814
Urol Ann. 2013 Apr;5(2):61-74
pubmed: 23798859
Urologe A. 2009 Jan;48(1):66-72
pubmed: 18696036
J Chemother. 2019 Feb;31(1):15-22
pubmed: 30508403
Eur Urol. 2005 Apr;47(4):549-56
pubmed: 15774257
J Urol. 2005 Apr;173(4):1175-81
pubmed: 15758736
J Urol. 2002 Feb;167(2 Pt 1):571-7
pubmed: 11792921
AMA Arch Intern Med. 1957 Nov;100(5):709-14
pubmed: 13468815
Eur Urol. 2008 Dec;54(6):1270-86
pubmed: 18423974
J Urol. 2020 Feb;203(2):351-356
pubmed: 31441676
Br J Urol. 1981 Aug;53(4):339-43
pubmed: 7020820
Urology. 1996 Jun;47(6):852-6
pubmed: 8677576
Clin Infect Dis. 2019 May 2;68(10):e83-e110
pubmed: 30895288
Eur Urol. 2001 Mar;39(3):272-6
pubmed: 11275718
N Engl J Med. 1982 Aug 19;307(8):463-8
pubmed: 7099208
Med Arch. 2014 Aug;68(4):249-53
pubmed: 25568546
PLoS One. 2016 Jul 08;11(7):e0157864
pubmed: 27391962
World J Urol. 2019 Nov;37(11):2467-2472
pubmed: 30739131
Cent European J Urol. 2017;70(3):252-258
pubmed: 29104787
J Urol. 1983 Sep;130(3):479-80
pubmed: 6350615

Auteurs

Selvin Theodore Jayanth (ST)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

J Chandrasingh (J)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Rani Diana Sahni (RD)

Department of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.

Rajiv Paul Mukha (RP)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Santosh Kumar (S)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Antony Devasia (A)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Nitin Sudhakar Kekre (NS)

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Classifications MeSH